Synergistic effect of thrombus aspiration and glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention

被引：0
|
作者：
Pyxaras, S. A. [1 ]
Mangiacapra, F. [1 ]
Di Serafino, L. [1 ]
Toth, G. [1 ]
De Vroey, F. [1 ]
Perkan, A. [2 ]
De Bruyne, B. [1 ]
Salvi, A. [2 ]
Sinagra, G. [2 ]
机构：
[1] OLV Hosp Aalst, Ctr Cardiovasc, Aalst, Belgium
[2] Univ Hosp Riuniti, Dept Cardiol, Trieste, Italy
来源：
EUROPEAN HEART JOURNAL | 2012年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：549 / 550
页数：2
相关论文
共 50 条
  • [1] Prognostic Role of Thrombus Aspiration and IIb/IIIa inhibitors during Primary Percutaneous Coronary Intervention
    Pyxaasi, Stylianos A.
    Rakar, Serena
    Perkan, Andrea
    Santangelo, Sara
    Vitrella, Giancarlo
    Barbali, Giulia
    Della Grazia, Erica
    Igidhashian, Diran
    Zalukar, Walter
    Antonaglia, Vittorio
    Morgera, Tullio
    Salvi, Alessandro
    Sinagra, Gianfranco
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (20) : B99 - B99
  • [2] Synergistic Effect of Thrombus Aspiration and Abciximab in Primary Percutaneous Coronary Intervention
    Pyxaras, Stylianos A.
    Mangiacapra, Fabio
    Verhamme, Katia
    Di Serafino, Luigi
    De Vroey, Frederic
    Toth, Gabor
    Perkan, Andrea
    Salvi, Alessandro
    Bartunek, Jozef
    De Bruyne, Bernard
    Wijns, William
    Sinagra, Gianfranco
    Barbato, Emanuele
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2013, 82 (04) : 604 - 611
  • [3] Safety of switching glycoprotein IIb/IIIa inhibitors for percutaneous coronary intervention
    Grabarczyk, MA
    Staton, S
    Applegate, RJ
    Sacrinty, M
    Baki, TT
    Gandhi, SK
    Little, WC
    Kutcher, MA
    Sane, DC
    Forest, W
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 37A - 37A
  • [4] Glycoprotein IIb/IIIa receptor inhibitors in percutaneous coronary intervention and acute coronary syndrome
    Crouch, MA
    Nappi, JM
    Cheang, KI
    [J]. ANNALS OF PHARMACOTHERAPY, 2003, 37 (06) : 860 - 875
  • [5] Glycoprotein IIb/IIIa inhibitors and bivalirudin in patients undergoing percutaneous coronary intervention
    Mahmoudi, M.
    Waksman, R.
    [J]. MINERVA CARDIOANGIOLOGICA, 2012, 60 (01): : 95 - 100
  • [6] Impact of thrombus aspiration and Glycoprotein IIb/IIIa inhibitor between new antiplatelet agents and clopidogrel in patients undergoing primary percutaneous coronary intervention
    Lee, J. H.
    Park, B. E.
    Park, Y. J.
    Kim, H. N.
    Kim, N. K.
    Song, J. H.
    Jang, S. Y.
    Bae, M. H.
    Yang, D. H.
    Park, H. S.
    Cho, Y.
    Chae, S. C.
    Jeong, M. H.
    [J]. EUROPEAN HEART JOURNAL, 2018, 39 : 1150 - 1151
  • [7] The role of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention for ST elevation myocardial infarction
    Svilaas, T
    van der Horst, ICC
    Zijlstra, F
    [J]. EUROPEAN HEART JOURNAL, 2005, 26 (23) : 2479 - 2481
  • [8] Thrombus Aspiration during Primary Percutaneous Coronary Intervention Improves Myocardial Reperfusion with and without Use of Platelet Glycoprotein IIb/IIIa Receptor Blockers.
    Kim, Byung Ok
    Lee, Byoung-Kwon
    Goh, Choong-Won
    Byun, Young-Sub
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (9A): : 44B - 44B
  • [9] Effect of clopidogrel loading before percutaneous coronary intervention in patients treated with glycoprotein IIb/IIIa inhibitors
    Assali, A
    Sdringola, S
    Salloum, J
    Moustapha, A
    Ghani, M
    Schroth, G
    Anderson, HV
    Smalling, RW
    Rosales, O
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 83A - 83A
  • [10] Cangrelor vs. glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention
    Yerasi, Charan
    Case, Brian C.
    Chezar-Azerrad, Chava
    Forrestal, Brian J.
    Medranda, Giorgio A.
    Shea, Corey
    Zhang, Cheng
    Ben-Dor, Itsik
    Satler, Lowell F.
    Bernardo, Nelson L.
    Hashim, Hayder
    Garcia-Garcia, Hector M.
    Waksman, Ron
    [J]. AMERICAN HEART JOURNAL, 2021, 238 : 59 - 65
12345